Methods
To study this question, we developed three reproducible measures that are inversely associated with TDLU involution: TDLU counts, median TDLU span, and median acini counts/TDLU. We determined factors associated with TDLU involution using normal breast tissues from 1938 participants (1369 premenopausal and 569 postmenopausal) ages 18 to 75 years in the Susan G. Komen Tissue Bank at the Indiana University Simon Cancer Center. Multivariable zero-inflated Poisson models were used to estimate relative risks (RRs) and 95% confidence intervals (95% CIs) for factors associated with TDLU counts, and multivariable ordinal logistic regression models were used to estimate odds ratios (ORs) and 95% CIs for factors associated with categories of median TDLU span and acini counts/TDLU.
Results
All TDLU measures started declining in the third age decade (all measures, two-sided P trend ≤ .001); and all metrics were statistically significantly lower among postmenopausal women. Nulliparous women demonstrated lower TDLU counts compared with uniparous women (among premenopausal women, RR = 0.79, 95% CI = 0.73 to 0.85; among postmenopausal, RR = 0.67, 95% CI = 0.56 to 0.79); however, rates of age-related TDLU decline were faster among parous women. Other factors were related to specific measures of TDLU involution.
Conclusion
Morphometric analysis of TDLU involution warrants further evaluation to understand the pathogenesis of breast cancer and assessing its role as a progression marker for women with benign biopsies or as an intermediate endpoint in prevention studies.
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Terminal duct lobular units (TDLUs) are the structures within the breast that produce milk and the primary source of most breast cancer precursors and cancers ( Figure 1 ) (1) . With completion of childbearing and physiological aging, TDLUs involute, resulting in a reduction in acini (substructures) number/TDLU and total TDLU counts (2-3). The determinants of age-related TDLU involution are undefined, and understanding these processes may elucidate factors associated with persistence of acini and TDLUs in later life, and elevated breast cancer risk (3) . Analysis of women who have undergone a breast biopsy, which showed benign breast disease (BBD), suggests that those who have less TDLU involution are more likely to develop breast cancer than those with greater degrees of involution, extending findings in rodent models linking mammary development, microanatomy, and cancer susceptibility (3) (4) (5) (6) (7) (8) (9) (10) (11) .
Standardized, reproducible quantitative measurements to evaluate TDLU involution have not been developed. An analysis of benign biopsies from 8756 women in the Mayo BBD Cohort found that the absence of TDLU involution, based on subjective assessment, was associated with a statistically significant increase in breast cancer risk (relative risk [RR] = 1.88, 95% CI = 1.59 to 2.21) compared with the general population (8) . Additional analyses in this cohort demonstrated that increased acini counts/TDLU or TDLU area were related to increased five-year risk independent of Gail model risk prediction (7) . Using an adaptation of a TDLU involution classification developed in rodent models (11) , the Nurses' Health Study II demonstrated a 29% reduction in cancer risk among women with BBD containing predominantly type 1 lobules (fewer than 12 acini) and lacking type 3 lobules (approximately 80 acini) (4) .
To date, studies of TDLU involution have been limited by a lack of access to large collections of epidemiologically annotated normal breast samples that were obtained for research as opposed to clinical diagnosis (3, 12) . The Susan G. Komen Tissue Bank at the Indiana University Simon Cancer Center (KTB) JNCI | Article 2 of 11 jnci.oxfordjournals.org addresses these limitations by providing a resource of normal breast tissues, risk factor data, and blood from volunteers for research (13) (14) . Given that the best method for assessing the level of TDLU involution is unknown, we performed morphometric assessment of TDLUs and developed three reproducible quantitative measures that are inversely associated with TDLU involution, TDLU counts per standardized biopsy, median acini counts/TDLU, and median TDLU span, in order to identify factors associated with TDLU involution in normal breast tissues from the KTB.
Methods

Study Population
The KTB biorepository of specimens from women volunteers is described in detail elsewhere (http://komentissuebank.iu.edu/) (13) (14) (15) . Donors provided written informed consent, and were recruited under a protocol approved by the Indiana University Institutional Review Board. The current project received additional approval from the National Institutes of Health (NIH) Office of Human Subjects Research (OHSR).
We received data from 2197 consented women aged 18 to 91 years who were enrolled in KTB from 2009 to 2012. Ten women without available tissues, 177 with a history of cancer (67 breast and 110 other sites), 18 who were pregnant, 37 with indeterminate menopausal status, and 17 older than 75 years were excluded, resulting in an analytical dataset of 1938 participants.
Exposure Assessment
Participants completed questionnaires asking about demographic characteristics, reproductive and menstrual history, medical history, family history of breast or ovarian cancer, medication use, gynecologic surgeries, and mammographic screening. Women were classified as current smokers, former smokers if they had previously smoked for one year or more, or nonsmokers. Among parous women, age at first birth was analyzed categorically (<25, 25-29, and ≥30 years). Women who breastfed for more than one month were classified as having ever breastfed. We classified women as postmenopausal: 1) if they reported that their menstrual periods had stopped at least 12 months prior to tissue donation (unrelated to oral contraceptive use), 2) had undergone a bilateral oophorectomy, or 3) had a hysterectomy without bilateral oophorectomy and were at least 55 years of age. Menopausal hormone use was categorized as current, former, or never. Body mass index (BMI) was calculated from reported weight and height (kg/m 2 ) and assessed categorically (<25 kg/m 2 , 25-29 kg/m 2 , ≥30 kg/m 2 ).
Breast Tissue Collection
Up to four tissue cores were removed from the upper outer quadrant of the breast (left or right) with a 10-gauge needle. One core was fixed in 10% buffered formalin, routinely processed as paraffin embedded blocks, sectioned, and stained with hematoxylin and eosin. Digitized images of these sections were used for analysis of TDLU involution (see below).
Histologic Assessment of TDLU Involution
Stained tissue sections were digitized at 20X magnification (Aperio ScanScope CS, Vista, CA), and prepared for web-based viewing and annotation with Digital Image Hub software (Slidepath/ Leica, Dublin, Ireland). Breast tissues containing TDLUs displaying focal benign changes (duct dilatation, metaplasia, hyperplasia) (13) were assessed, provided that normal TDLUs were present (8, 16 ). TDLUs were not evaluated if more than half the acini were dilated two to three times the normal diameter or if ); TDLU counts and TDLU counts per mm 2 were highly correlated (Spearman rho = 0.98), and only the former is presented. Up to 10 normal TDLUs were reviewed sequentially to assess: 1) TDLU span, measured with an electronic ruler (microns) and 2) acini counts/TDLU in categories (1 = ≤10, 2 = 11-20, 3 = 21-30, 4 = 31-50, 5 = >50) (Figure 1 ), to provide stable representative measures of TDLU involution (7, (17) (18) . For acini counts/TDLU and TDLU span measures, we used the median of the values obtained across the multiple TDLUs measured for each woman.
Intraobserver agreement for the reviewer (MES) demonstrated Spearman correlation coefficients greater than .90 for all comparisons; an interobserver reproducibility analysis among three independent reviewers including MES, yielded Spearman correlations ranging between .66 and .96 (see the Supplementary Materials, available online). TDLU counts showed the highest correlation between pathologists, (rho ≥ 0.86), followed by median acini (rho ≥ 0.71), and TDLU span measures (rho ≥ 0.66). The three TDLU measures were correlated with qualitative assessment of TDLU involution, which has been previously demonstrated to predict breast cancer risk among women with benign breast biopsies (see the Supplementary Materials, available online, for details) (13) .
Statistical Analysis
Relationships between TDLU measures (TDLU counts, median TDLU span, and median category of acini counts/TDLU) were assessed with Spearman correlations. A lowess function was used to estimate and plot the average of TDLU measures as a function of age (19) . Change-point analysis was performed to assess if slopes of mean TDLU measures changed in relation to age (22) . Subsequent analyses were separated by menopausal status and adjusted for age. We included factors in multivariable analysis if they were associated with a P trend less than .05 or if any level of a categorical variable yielded P less than .05. Only results of multivariable models are presented. TDLU counts included a substantial number of samples with zero counts, and thus a standard Poisson model did not provide an adequate fit to the data. Relative risk (RRs) and 95% confidence intervals (CIs) were estimated using zero-inflated Poisson regression, an extension of Poisson regression that can accommodate the high number of zero values (20) . Median TDLU span and acini/TDLU were categorized into tertiles. Associations of lifestyle/demographic factors and categories of median TDLU span and acini/TDLU were assessed using ordinal logistic regression models (odds ratios [ORs] and 95% CIs) (21) . Analyses included all subjects and were adjusted for racial/ethnic group.
A lowess function was used to estimate and plot the average of TDLU measures as a function of age, separately for parous and nulliparous women. Age at last birth was not assessed on the questionnaire, therefore, age at last birth and time since last birth were only available for uniparous women. Thus, we imputed age at last birth to also calculate time since last birth for multiparous women and accounted for the imputation in the association analysis (see the Supplementary Materials, available online, for details). Associations between exposures and TDLU measurements were evaluated for statistical significance using Wald tests. Analyses were performed using SAS9.3. Plots were created in R using the "lowess" function. All statistical tests were two-sided, and a P value of less than .05 was considered statistically significant.
results
Characteristics of Subjects
Select characteristics of participants are presented in Table 1 . Participants were predominantly non-Hispanic white, premenopausal, and highly educated. Among premenopausal women, 51.0% were nulliparous and 31.6% were current users of hormonal birth control. Among postmenopausal women, 27.3% reported having undergone a prior breast biopsy, 40.1% had a body mass index Age, Menopausal Status and TDLU Involution TDLU counts were weakly correlated with TDLU span (Spearman rho = 0.16, P < .001) and with acini counts/TDLU (Spearman rho = 0.18, P < .001); TDLU span and acini counts/ TDLU were more strongly correlated (Spearman rho = 0.70, P < .001). All TDLU measures declined with advancing age, although the patterns of decline differed slightly between the measures (Figure 2) . Statistically significant slope changes were noted for TDLU counts and acini counts/TDLU at age 44 years and at age 49 years for TDLU span.
In models adjusted for menopausal status, compared with women less than age 30 years, statistically significant declines starting at ages 40 to 49 years were found for TDLU counts (RR = 0.87, 95% CI = 0.83 to 0.91) and for acini counts/TDLU (OR = 0.54, 95% CI = 0.40 to 0.74). For TDLU span, declines occurred a decade earlier at ages 30 to 39 years (OR = 0.64, 95% CI = 0.48 to 0.87). All three TDLU measures were lower among postmenopausal as compared with A descriptive summary of the median and range of TDLU measurements by age and stratified by menopausal status is shown in Table 2 . TDLU measurements displayed considerable variation among women; generally TDLU measures fell dramatically with age, with the exception of acini counts among postmenopausal women.
Parity and TDLU Involution
In multivariable zero-inflated Poisson models among premenopausal (Table 3) and postmenopausal (Table 4 ) women, nulliparous women had fewer TDLUs compared with uniparous women (premenopausal women: RR = 0.79, 95% CI = 0.73 to 0.85; postmenopausal women: RR = 0.67, 95% CI = 0.56 to 0.79). Among parous women, an increasing number of live births was associated with increasing TDLU counts (premenopausal P trend = .01, postmenopausal P trend = .007).
Relationships between TDLU counts and age differed statistically significantly across nulliparous and parous women (P interaction ≤.001) (Figure 3 ). Among nulliparous women, TDLU counts declined at a slower rate with increasing age compared with parous women. TDLU counts were highest for parous compared with nulliparous women between ages 20 to 40 years, and then differences narrowed with advancing age, reaching equivalence around age 70 years. No differences were found for TDLU span or acini counts/TDLU by parity status.
Among uniparous women, age-adjusted analyses demonstrated that TDLU metrics declined in relation to time since last birth (Supplementary Table 1 ). In analyses in which missing data for age at last birth for multiparous women was imputed, TDLU measures showed the greatest declines approximately a decade following birth.
Time since first live birth was not statistically significantly associated with TDLU measures among multiparous women (data not shown).
Influence of Other Factors on TDLU Counts, Span, and Acini Counts/TDLU
Other factors were variably associated with specific TDLU metrics (Tables 3 and 4; Supplementary Tables 2-4 , available online). Among premenopausal women, compared with never smokers, former and current smokers had fewer TDLU counts (Table 3) , shorter spans (Supplementary Table 2 , available online), and fewer acini/TDLU (Supplementary Table 3 , available online). Among postmenopausal women, compared with never smokers, former and current smokers had shorter spans (Supplementary Table 4 , available online). A positive family history of breast cancer was associated with higher TDLU counts in both premenopausal (Table 3) and postmenopausal women (Table 4) , and possibly TDLU span among premenopausal women with two or more affected relatives (based on 19 individuals) (Supplementary Table 2 , available online). Among postmenopausal women, older ages at menarche showed an association with fewer TDLUs (Table 4) . Compared with never users of menopausal hormone therapy, former users had fewer TDLUs (Table 4 ) and smaller TDLU spans (Supplementary Table 4 , available online); current users did not have statistically significant differences in counts, but they had statistically significantly larger TDLU spans (Supplementary Table 4 , available online). TDLUs were identified among 50.8% of oophorectomized women as compared with 60.7% of those with intact ovaries. In zero-inflated Poisson regression, women who had an oophorectomy were more likely to not have TDLUs, but among samples in which TDLUs were identified, oophorectomy was associated with greater TDLU counts (Table 4) . Specimens with greater percentage of fat were associated with lower TDLU counts in both pre- (Table 3 ) and postmenopausal women (Table 4) , and with fewer Our data show that TDLU involution begins prior to menopause and deepens after the transition, as would be expected with aging and cessation of ovarian hormone production. In addition, * Relative risk and 95% confidence intervals were obtained from zero-inflated Poisson models. Poisson model was fit to both 0 and 1+ terminal duct lobular unit counts so that the groups jointly equaled to total subjects, and covariates were selected for inclusion in multivariable models if their trend or Wald test or any category was associated at P < .05. CI = confidence interval; RR = relative risk; TDLU = terminal duct lobular unit. † Two-sided P value for trend test. ‡ Two-sided P value for Wald type 3 test. § Two-sided P value calculated for parous and nulliparous women.
ǁ P value for trend among parous women only.
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we found that parous women have less TDLU involution than nulliparous women throughout life, possibly with the greatest effect within 10 years of delivery, consistent with earlier reports (8, 16) .
The hyperplastic effects of pregnancy may underlie the dualistic influences of parity, which is suggested to increase breast cancer risk in the short term and reduce risk in the long term in some studies (23) (24) (25) . More specifically, parity may increase risk for aggressive estrogen receptor (ER)-negative/basal-like breast cancers and * Relative risk and 95% confidence intervals were obtained from zero-inflated Poisson regression models adjusted for age and all factors that showed an association with terminal duct lobular unit (TDLU) counts at P < .05. Poisson model was fit to both 0 and 1+ TDLU counts so that the groups jointly equaled to total subjects, and covariates were selected for inclusion in multivariable models if their trend or Wald test or any category was associated at P < .05. CI = confidence interval; RR = relative risk; TDLU = terminal duct lobular unit. † Two-sided P value for trend test. ‡ Two-sided P value for Wald type 3 test. § Two-sided P value calculated for parous and nulliparous women.
ǁ P value for trend among parous women only. decrease risk for ER-positive luminal A cancers, which predominate at older ages (26) (27) (28) (29) (30) (31) (32) . In gravid rodents, hormones, particularly progesterone, are implicated in proliferation of breast epithelium and massive expansion of stem cells during pregnancy (33) . Data also suggest that pregnancy may disproportionately reduce luminal as compared with basal stem cell populations (33) (34) (35) (36) . After weaning, breast epithelium undergoes apoptosis and the organ is remodeled, typically restoring the gland to a nonparous, although differentiated state (37) (38) (39) . However, animal data suggest that postpartum involution may potentiate tumor aggressiveness (40) (41) (42) , paralleling the poor prognosis of pregnancy associated breast cancers among women (40, (43) (44) . In years following a birth, TDLU epithelium shows reduced expression of ER-α, progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) and increased ER-β, which may partially mediate the observed longterm protective effect of parity (42) . Although postpartum involution and age-related involution are mechanistically distinctive processes, the effects of these events on TDLU involution are difficult to separate (12, 40) . Family history, current use of menopausal hormones and early age at menarche were variably (and perhaps less certainly) associated with less TDLU involution and increased breast cancer risk. Former menopausal hormone users demonstrated increased TDLU involution, consistent with the proposal that withdrawing estrogen induces apoptosis and lowers risk (45) . Breastfeeding was associated with more TDLU involution among premenopausal women, but less involution in postmenopausal women, perhaps indicating greater influence on TDLU involution prior to menopause. Smoking was associated with increased TDLU involution, consistent with its role in shifting circulating estrogen profiles towards less potent metabolites (46) (47) (48) (49) . Our results for relationships of oophorectomy and TDLU involution are difficult to interpret: As expected, oophorectomy was associated with a lower percentage of identifiable TDLUs, but among samples containing TDLUs our data suggested that oophorectomy was associated with higher TDLU counts, which may reflect chance.
Strengths of this study include assessment of a large, demographically diverse group of tissue donors, use of standardized and optimized sample collection procedures, and TDLU characterization using quantitative reproducible metrics. Of the three metrics, TDLU span and acini/TDLU were strongly correlated, but weakly related to TDLU counts. These correlations may reflect sequential reduction in TDLU size followed by disappearance or a difference in effects of hormones or other factors on breast microanatomy (11) . Lack of TDLUs may reflect complete involution, sometimes suggested by the presence of naked ducts, but in other instances, this may reflect nonrepresentative sampling. We adjusted TDLU data for percentage fat in tissue sections because this factor was inversely associated with TDLU counts, potentially reflecting undersampling of TDLUs or fatty replacement occurring with true involution. Greater degrees of TDLU involution have been associated with lower mammographic density, reflecting increased fat content (5,10). Our study and prior research show that small breast samples are generally representative of TDLU involution in the breast (16) (17) , and misclassification would likely bias associations to the null. Other possible limitations of our study include the limited size of the tissue samples, and the missing information on age at last birth for multiparous women, which is needed to calculate time since last birth. In addition, our findings are based on a population of self-selected volunteers enriched for family history of breast cancer, which may limit generalizability of findings.
In conclusion, we identified factors associated with TDLU involution, of which age, menopause and parity were prominent. Levels of TDLU involution were highly variable among women, suggesting that further research is needed to understand the factors that influence TDLU involution, and therefore, may influence breast cancer risk. In particular, our study revealed several factors with weak or suggestive associations with TDLU involution, Age at tissue collection TDLU counts Parous Nulliparous Figure 3 . Impact of parity on the association between TDLU counts and age. A lowess function was used to estimate the average of TDLU counts stratified by parity status as a function of age. TDLU = terminal duct lobular unit.
JNCI | Article 10 of 11 jnci.oxfordjournals.org which require confirmation to firmly establish the relationships. The observed association of parity with increased TDLU counts suggests that further research on lactation and postpartum remodeling may provide clues about the pathogenesis of certain subtypes of breast cancer and their prevention (40, 50) . Our analysis highlights the need for further consideration of age since last birth as a factor in risk assessment, since currently, time since last birth is not an established risk factor. Further, morphometric TDLU assessment over the life course, including analyses aimed at determining why some women involute more than others, may have value for understanding breast carcinogenesis. Studies of TDLU involution are needed to assess its potential as a progression marker for women with BBD, and as intermediate endpoints in prevention studies.
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